SCHEMBL9583879

SCHEMBL9583879

CC(C)C(=O)OCCCOC(OC(=O)C(C)C)n1cnc2c(N)ncnc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 2/20 0.48
▸ ADORA2B P29275 2/20 0.48
▸ ADORA1 P30542 2/20 0.48
▸ PI4KA P42356 1/20 0.48
▸ PI4K2B Q8TCG2 1/20 0.48
▸ PI4K2A Q9BTU6 1/20 0.48
▸ PI4KB Q9UBF8 1/20 0.48
▸ ADA P00813 4/20 0.44
▸ PDE2A O00408 3/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ PDE4A P27815 1/20 0.44
▸ PDE4B Q07343 1/20 0.44
▸ PDE4C Q08493 1/20 0.44
▸ PDE4D Q08499 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10813829 0.85 ADORA2A (0.45) ADORA2AADORA2BADORA1PI4KAPI4K2B
SCHEMBL10817431 0.83 ADA (0.47) ADORA2AADORA2BADORA1PI4KAPI4K2B
SCHEMBL9594480 0.79 HK1 (0.43) CYP3A4ALDH1A1CYP1A2HIF1ALMNA
SCHEMBL9583596 0.78 ADA (0.41) ADORA2AADORA2BADORA1ADAPDE2A
SCHEMBL9584502 0.78 CDK1 (0.49) AHCY
SCHEMBL9584828 0.77 CCNB2 (0.40) ADORA2AADORA2BADORA1PDE4APDE4B
SCHEMBL10818132 0.77 ADORA2A (0.48) ADORA2AADORA2BADORA1PI4KAPI4K2B
SCHEMBL9583290 0.76 CDK5 (0.42) KDM4E
SCHEMBL9583170 0.72 CDK1 (0.47) KDM4EALDH1A1HSD17B10
SCHEMBL9583624 0.72 CYP1A2 (0.40) CYP1A2SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5250535-A Herpes virus; nontoxic; side effect reduction; humans and veterinary medicine SYNTEX INC. (US) 1993-10-05 — — US disclosed
US-4803271-A Process for preparing guanine derivatives SYNTEX (U.S.A.) INC. (US) 1989-02-07 — — US disclosed
US-4612314-A Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent SYNTEX (U.S.A.) INC. (US) 1986-09-16 — — US disclosed
EP-0085424-A2 Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl)purines as antiviral agent SYNTEX (U.S.A.) INC. (US) 1983-08-10 — — EP disclosed
Send feedback